Sepsis: Page 2

Biocartis to present 9 abstracts on MDx platform, assays at AMP 2022
One study evaluates the performance of the Immunexpress SeptiCyte Rapid ethylenediamine tetraacetic acid blood-compatible cartridges on the Idylla platform.
October 31, 2022
Sepsis Bacteria Social
Avails Medical nabs $1.7M to develop AST test
The money will be used to further develop the fully electrical Avails Medical eAST system, which provides a time-to-results average of five hours. The system will enable healthcare providers to determine the most effective antibiotic treatment for patients with severe bloodstream infections, such as sepsis, particularly those involving multidrug-resistant pathogens.
August 31, 2022
2022 09 01 16 42 9125 Lab Chemical Screening 400
Immunexpress adds undiluted EDTA to blood samples
SeptiCyte Rapid is a sample-to-answer, cartridge-based, molecular test for sepsis that uses reverse transcription polymerase chain reaction (RT-PCR) to quantify the relative expression levels of host response genes isolated from whole blood.
August 22, 2022
2022 07 06 15 42 9216 Diagnose Sepsis 400
Accelerate Diagnostics prices $35M stock offering
Its gross proceeds from the offering, before deductions, are expected to be $35 million, said Accelerate, a Tucson, AZ-based developer and supplier of identification and antimicrobial susceptibility tests (ID/AST) for bloodstream infections including sepsis.
August 18, 2022
2022 07 08 16 10 0843 Research Money 400
VolitionRx inks research deal with MD Anderson
Financial and other terms of the agreement were not disclosed.
August 10, 2022
2020 06 19 20 57 0712 Sepsis Bacteria 400
Abionic nabs IVDR certification for sepsis test
The device detects pancreatic stone protein, an early marker for sepsis, allowing for its identification in about five minutes, Abionic said.
August 8, 2022
2020 06 19 20 57 0712 Sepsis Bacteria 400
Video from AACC: Cytovale immune-response test for sepsis
The San Francisco-based startup has submitted an application to the U.S. Food and Drug Administration (FDA) for clearance of the system and test, which aims to help emergency departments to more effectively and quickly triage patients.
July 28, 2022
2022 07 29 16 04 7496 Shah 400
Cytovale to present new data on rapid sepsis test at AACC
The firm noted it has already submitted an application to the U.S. Food and Drug Administration for clearance of the system and test, which aims to help emergency departments rapidly and more effectively triage patients.
July 24, 2022
2022 07 06 15 42 9216 Diagnose Sepsis 400
Nanomix, Biotron ink distribution deal
Under the terms of the deal, Biotron also will market the Nanomix S1 panel cartridge, which diagnoses infections, including sepsis, and future new product cartridges for the eLab system.
July 20, 2022
2022 07 21 20 13 5060 Scientists Lab Microscope 400
Bluejay Diagnostics completes clinical studies for sepsis triage
The Acton, MA-based firm said it will present the study results at the 2022 AACC Annual Scientific Meeting being held from July 26 to July 28 in Chicago.
July 5, 2022
2022 07 06 15 42 9216 Diagnose Sepsis 400
Nanomix launches trial of eLab analyzer and panel
The company's eLab system is a mobile, handheld immunoassay and chemistry diagnostic system designed for rapid point-of-care testing, while the S1 Panel Cartridge was developed to aid in diagnosing critical infections, including sepsis. The panel provides quantitative test results for procalcitonin (PCT), C-reactive protein (CRP), and lactate (LAC) from a single venous whole blood or plasma sample type.
June 22, 2022
2021 10 06 20 31 5504 Nanotechnology 400
Pathogenomix gets FDA designation for Patho-Seq assay
Patho-Seq was designed for the rapid detection and identification of hundreds of clinically relevant bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from cerebrospinal fluid, Pathogenomix said.
January 19, 2022
2019 07 15 17 19 4107 Bacteria Blood Sepsis 400
Previous Page
Page 2 of 5
Next Page